Northland Capital Upgrades Piper Sandler on Advisory Business Momentum
Northland Capital (also referred to as Northland Securities) has upgraded Piper Sandler Companies (NYSE: PIPR) from Market Perform to Outperform, establishing a price target of $350. The upgrade comes after shares recently fell below $300 for the first time since July 2025, presenting what the firm views as an attractive entry point amid strengthening fundamentals in the company’s advisory business.
Why the Rating Changed
Northland’s upgrade is rooted in several specific factors related to Piper Sandler’s advisory operations and strategic positioning:
- Advisory business inflection point: Northland cited an inflection point in Piper Sandler’s advisory business as the primary driver of its more constructive outlook. The firm pointed to strong momentum at the end of 2025 and a growing mergers and acquisitions pipeline heading into 2026.
- Share price pullback creating opportunity: With PIPR shares dipping below $300 for the first time since July 2025, Northland appears to view the recent decline as a disconnect between the stock price and the company’s improving business trajectory. The $350 price target implies meaningful upside from current levels.
- Healthcare franchise expansion: Piper Sandler has been actively building out its healthcare investment banking capabilities. The company recently appointed Jason Arnold as a managing director focused on life science tools and diagnostics and named Aamer Naseer as global head of life sciences outsourcing and B2B med tech. These hires suggest a deliberate strategy to strengthen the firm’s presence in high-margin healthcare advisory niches.
- Broader analyst consensus: Piper Sandler currently carries an average recommendation of “Moderate Buy” across the six analysts covering the stock, indicating that Northland’s constructive view is broadly aligned with the Street’s sentiment, though individual ratings range from sell to outperform.
Taken together, the combination of a growing M&A pipeline, strategic investments in specialized advisory verticals like healthcare, and a recent stock price pullback appears to have prompted Northland to take a more bullish stance on PIPR.
Dividend Overview
Piper Sandler currently pays an annual dividend of $2.80 per share, which translates to a dividend yield of approximately 0.94%. The most recent ex-dividend date was March 2, 2026. While the yield is modest, it is consistent with the profile of a mid-cap investment bank that tends to prioritize reinvestment in the business and employee compensation alongside shareholder returns. For dividend-focused investors, PIPR is more likely to appeal as a total return opportunity — combining capital appreciation potential with a supplementary income stream — rather than as a high-yield holding.
Analyst Rating Summary
- Analyst Firm: Northland Capital (Northland Securities)
- Previous Rating: Market Perform
- New Rating: Outperform
- Price Target: $350
- Consensus Rating (6 analysts): Moderate Buy
Disclaimer: This article is for informational purposes only and does not constitute financial advice, a recommendation, or a solicitation to buy or sell any securities. Investors should conduct their own research and consult with a qualified financial advisor before making investment decisions.